Viewing Study NCT05874635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-01-27 @ 7:24 AM
Study NCT ID: NCT05874635
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-29
First Post: 2023-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Sponsor: Signos Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Weight Loss View
None Metabolic Syndrome View
None Diabetes Mellitus, Type 2 View
None Central Obesity View
None Insulin Resistance View
None Glucose Intolerance View
None Metabolic Glucose Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None health and wellness View
None excess adiposity View